awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34456352-7EC259B0-094E-4575-BBEA-D7D9639C87FB
Q34456352-7EC259B0-094E-4575-BBEA-D7D9639C87FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34456352-7EC259B0-094E-4575-BBEA-D7D9639C87FB
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.
P2860
Q34456352-7EC259B0-094E-4575-BBEA-D7D9639C87FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34456352-7EC259B0-094E-4575-BBEA-D7D9639C87FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68da4827573bc809b6de08e6b524ad9cddfbcb40
P2860
Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates.